MedImmune Ventures, Inc.
CIK 1291884 · View on SEC EDGAR ↗
First SEC filing: Feb. 17, 2015 · Latest: Feb. 17, 2015
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2015 | RCKTW | P | 416,667 | $6.00 | $2,500,002 | 1,917,906 Indirect | +27.75% | Acquired | -100.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 23, 2015 | RCKTW | Convertible Promissory Notes | Common Stock (57,204) | — | — | 338,551 | Disposed |
| Feb. 23, 2015 | RCKTW | Series AA Convertible Preferred Stock | Common Stock (1,255,123) | — | — | 4,013,692 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.